Skip NavigationSkip to Content

Role of Ets/Id proteins for telomerase regulation in human cancer cells

  1. Author:
    Xiao, X. D.
    Athanasiou, M.
    Sidorov, I. A.
    Horikawa, I.
    Cremona, G.
    Blair, D.
    Barret, J. C.
    Dimitrova, D. S.
  2. Author Address

    NCI, Lab Expt & Computat Biol, NIH, Bldg 469,Rm 246,Rm 139,POB B,Miller Dr, Frederick, MD 21702 USA NCI, Lab Expt & Computat Biol, NIH, Frederick, MD 21702 USA NCI, Lab Biosyst & Canc, CCR, NIH, Bethesda, MD 20892 USA NCI, Basic Res Program, SAIC Frederick Inc, Frederick, MD 21702 USA NCI, Basic Res Lab, CCR, NIH, Frederick, MD 21702 USA Xiao XD NCI, Lab Expt & Computat Biol, NIH, Bldg 469,Rm 246,Rm 139,POB B,Miller Dr, Frederick, MD 21702 USA
    1. Year: 2003
  1. Journal: Experimental and Molecular Pathology
    1. 75
    2. 3
    3. Pages: 238-247
  2. Type of Article: Article
  1. Abstract:

    Most human cancers express telomerase but its activity is highly variable and regulated by complex mechanisms. Recently, we have proposed that Ets proteins may be important for regulation of telomerase activity in leukemic cells. Here we provide further evidence for the role of Ets family members and related Id proteins in telomerase regulation and characterize the underlying molecular mechanisms. By using PCR-based and gel shift assays we demonstrated specific binding to a core hTERT promoter of Ets2, Fli1, Id2, c-Myc, Mad1, and Sp1 in lysates from subclones of U937 cells. Further analysis of binding of purified proteins and various mutants of the hTERT promoter suggested the existence of a trimolecular Ets-Id2-DNA complex, and Ets inhibitory activity mediated by c-Myc and the Ets binding site on the core hTERT promoter at -293 bp from the transcription initiation site as well as a positive Ets regulatory effect mediate through another Ets binding site at - 36 bp. This analysis provided evidence for the existence of negative and positive Ets regulatory site and suggested a complex interplay between Ets/Id family members and c-Myc that may be an important determinant of the diversity of telomerase activity in leukemia and other cancers. (C) 2003 Elsevier Inc. All rights reserved.

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel